

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 4.55796899 |
| 2 | central nervous system myelination (GO:0022010) | 4.55796899 |
| 3 | cytoplasmic mRNA processing body assembly (GO:0033962) | 4.48891345 |
| 4 | ensheathment of neurons (GO:0007272) | 3.73327770 |
| 5 | axon ensheathment (GO:0008366) | 3.73327770 |
| 6 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.68934690 |
| 7 | myelination (GO:0042552) | 3.67869433 |
| 8 | histone H3-K9 demethylation (GO:0033169) | 3.54078900 |
| 9 | protein localization to endosome (GO:0036010) | 3.33638802 |
| 10 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.33164484 |
| 11 | regulation of ARF protein signal transduction (GO:0032012) | 3.27802599 |
| 12 | regulation of histone H3-K27 methylation (GO:0061085) | 3.23715005 |
| 13 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 3.22384792 |
| 14 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 3.22384792 |
| 15 | myelin maintenance (GO:0043217) | 3.13376416 |
| 16 | corticosteroid receptor signaling pathway (GO:0031958) | 3.07472040 |
| 17 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 3.03394197 |
| 18 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 3.03394197 |
| 19 | histone H3-K4 trimethylation (GO:0080182) | 3.03263495 |
| 20 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.02555201 |
| 21 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.00779882 |
| 22 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.00579727 |
| 23 | growth hormone receptor signaling pathway (GO:0060396) | 2.99187851 |
| 24 | negative regulation of myotube differentiation (GO:0010832) | 2.94107985 |
| 25 | * peptidyl-threonine phosphorylation (GO:0018107) | 2.92905604 |
| 26 | histone demethylation (GO:0016577) | 2.89575705 |
| 27 | regulation of RNA export from nucleus (GO:0046831) | 2.88505693 |
| 28 | asymmetric protein localization (GO:0008105) | 2.88407167 |
| 29 | response to lipoprotein particle (GO:0055094) | 2.86375392 |
| 30 | nuclear pore organization (GO:0006999) | 2.85750296 |
| 31 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.85720035 |
| 32 | peripheral nervous system axon ensheathment (GO:0032292) | 2.85665110 |
| 33 | myelination in peripheral nervous system (GO:0022011) | 2.85665110 |
| 34 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.85000018 |
| 35 | creatine metabolic process (GO:0006600) | 2.83778433 |
| 36 | establishment of nucleus localization (GO:0040023) | 2.83737644 |
| 37 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.82136474 |
| 38 | embryonic process involved in female pregnancy (GO:0060136) | 2.80834769 |
| 39 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.77341832 |
| 40 | cell-substrate adherens junction assembly (GO:0007045) | 2.75355732 |
| 41 | focal adhesion assembly (GO:0048041) | 2.75355732 |
| 42 | * peptidyl-threonine modification (GO:0018210) | 2.75206306 |
| 43 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.73583585 |
| 44 | astrocyte development (GO:0014002) | 2.73006113 |
| 45 | gas transport (GO:0015669) | 2.72402509 |
| 46 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.71424793 |
| 47 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.71359814 |
| 48 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.71359814 |
| 49 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.71359814 |
| 50 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.70227048 |
| 51 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.70067806 |
| 52 | cellular response to epinephrine stimulus (GO:0071872) | 2.69633397 |
| 53 | cortical actin cytoskeleton organization (GO:0030866) | 2.66847875 |
| 54 | nerve growth factor signaling pathway (GO:0038180) | 2.65745802 |
| 55 | cellular response to growth hormone stimulus (GO:0071378) | 2.64909016 |
| 56 | adherens junction assembly (GO:0034333) | 2.62931456 |
| 57 | cell-substrate junction assembly (GO:0007044) | 2.62788403 |
| 58 | nucleus localization (GO:0051647) | 2.62009939 |
| 59 | pre-miRNA processing (GO:0031054) | 2.61877124 |
| 60 | erythrocyte development (GO:0048821) | 2.60058715 |
| 61 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.58580371 |
| 62 | oxygen transport (GO:0015671) | 2.58338347 |
| 63 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.56417618 |
| 64 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.56005436 |
| 65 | pore complex assembly (GO:0046931) | 2.55161174 |
| 66 | protein targeting to plasma membrane (GO:0072661) | 2.53524588 |
| 67 | positive regulation of receptor recycling (GO:0001921) | 2.53377791 |
| 68 | negative regulation of histone methylation (GO:0031061) | 2.53200673 |
| 69 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.52638188 |
| 70 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.51307194 |
| 71 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.47901024 |
| 72 | negative regulation of protein localization to cell surface (GO:2000009) | 2.47256891 |
| 73 | protein demethylation (GO:0006482) | 2.47126519 |
| 74 | protein dealkylation (GO:0008214) | 2.47126519 |
| 75 | regulation of response to osmotic stress (GO:0047484) | 2.47067780 |
| 76 | cerebellar granule cell differentiation (GO:0021707) | 2.46865135 |
| 77 | membrane raft organization (GO:0031579) | 2.46207008 |
| 78 | regulation of protein polyubiquitination (GO:1902914) | 2.46078788 |
| 79 | regulation of Rap GTPase activity (GO:0032317) | 2.45989698 |
| 80 | N-terminal protein amino acid acetylation (GO:0006474) | 2.45852633 |
| 81 | positive T cell selection (GO:0043368) | 2.44580710 |
| 82 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.43177082 |
| 83 | positive regulation of mRNA catabolic process (GO:0061014) | 2.41662778 |
| 84 | definitive hemopoiesis (GO:0060216) | 2.41632423 |
| 85 | Golgi to endosome transport (GO:0006895) | 2.41557234 |
| 86 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.40915082 |
| 87 | cortical cytoskeleton organization (GO:0030865) | 2.40492314 |
| 88 | mesodermal cell differentiation (GO:0048333) | 2.39784236 |
| 89 | regulation of mRNA 3-end processing (GO:0031440) | 2.39553091 |
| 90 | import into cell (GO:0098657) | 2.39448608 |
| 91 | cellular response to catecholamine stimulus (GO:0071870) | 2.39166663 |
| 92 | cellular response to monoamine stimulus (GO:0071868) | 2.39166663 |
| 93 | histone lysine methylation (GO:0034968) | 2.39162569 |
| 94 | negative regulation of DNA repair (GO:0045738) | 2.37812066 |
| 95 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.37690407 |
| 96 | photoreceptor cell differentiation (GO:0046530) | 2.37483197 |
| 97 | eye photoreceptor cell differentiation (GO:0001754) | 2.37483197 |
| 98 | hemoglobin metabolic process (GO:0020027) | 2.35939282 |
| 99 | positive regulation of macroautophagy (GO:0016239) | 2.34684997 |
| 100 | iron ion import (GO:0097286) | 2.33437714 |
| 101 | glomerular filtration (GO:0003094) | 2.32499709 |
| 102 | coronary vasculature morphogenesis (GO:0060977) | 2.32349537 |
| 103 | peptidyl-serine phosphorylation (GO:0018105) | 2.32333942 |
| 104 | renal filtration (GO:0097205) | 2.31229491 |
| 105 | regulation of mRNA catabolic process (GO:0061013) | 2.30772679 |
| 106 | cardiac myofibril assembly (GO:0055003) | 2.30726773 |
| 107 | myofibril assembly (GO:0030239) | 2.29617458 |
| 108 | establishment of spindle orientation (GO:0051294) | 2.29325060 |
| 109 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.28657632 |
| 110 | embryonic eye morphogenesis (GO:0048048) | 2.28038592 |
| 111 | apical protein localization (GO:0045176) | 2.27643570 |
| 112 | positive regulation of mRNA 3-end processing (GO:0031442) | 2.27389215 |
| 113 | virion attachment to host cell (GO:0019062) | 2.26881471 |
| 114 | adhesion of symbiont to host cell (GO:0044650) | 2.26881471 |
| 115 | histone H3-K36 demethylation (GO:0070544) | 2.26833960 |
| 116 | dosage compensation (GO:0007549) | 2.26331782 |
| 117 | regulation of necroptotic process (GO:0060544) | 2.25925195 |
| 118 | fibroblast migration (GO:0010761) | 2.23222191 |
| 119 | histone H3-K4 methylation (GO:0051568) | 2.22772624 |
| 120 | negative regulation of vascular permeability (GO:0043116) | 2.22643983 |
| 121 | mitotic sister chromatid cohesion (GO:0007064) | 2.20784812 |
| 122 | cellular hyperosmotic response (GO:0071474) | 2.20691074 |
| 123 | sodium ion export (GO:0071436) | 2.18605589 |
| 124 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.18539962 |
| 125 | cell communication by electrical coupling (GO:0010644) | 2.18235943 |
| 126 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.17994175 |
| 127 | response to epidermal growth factor (GO:0070849) | 2.17956447 |
| 128 | protein export from nucleus (GO:0006611) | 2.17621051 |
| 129 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.17578544 |
| 130 | negative regulation of neurotransmitter transport (GO:0051589) | 2.17541773 |
| 131 | establishment of spindle localization (GO:0051293) | 2.17079463 |
| 132 | negative regulation of inclusion body assembly (GO:0090084) | 2.16520945 |
| 133 | NLS-bearing protein import into nucleus (GO:0006607) | 2.15318894 |
| 134 | response to epinephrine (GO:0071871) | 2.14893292 |
| 135 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.14840290 |
| 136 | thymic T cell selection (GO:0045061) | 2.14306029 |
| 137 | regulation of T cell tolerance induction (GO:0002664) | 2.14173823 |
| 138 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.13696671 |
| 139 | protein targeting to Golgi (GO:0000042) | 2.13225065 |
| 140 | cardiac muscle hypertrophy (GO:0003300) | 2.13064605 |
| 141 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.11708650 |
| 142 | negative regulation of striated muscle cell differentiation (GO:0051154) | 2.11569236 |
| 143 | peptidyl-lysine trimethylation (GO:0018023) | 2.10979661 |
| 144 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.10606051 |
| 145 | heart morphogenesis (GO:0003007) | 2.08306055 |
| 146 | activated T cell proliferation (GO:0050798) | 2.07607072 |
| 147 | membrane tubulation (GO:0097320) | 2.05758091 |
| 148 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.05735893 |
| 149 | sarcomere organization (GO:0045214) | 2.05222351 |
| 150 | establishment of protein localization to Golgi (GO:0072600) | 2.04275336 |
| 151 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.03811136 |
| 152 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.01769213 |
| 153 | Rap protein signal transduction (GO:0032486) | 1.98595034 |
| 154 | nuclear pore complex assembly (GO:0051292) | 1.97638134 |
| 155 | interkinetic nuclear migration (GO:0022027) | 1.97563263 |
| 156 | negative regulation of T-helper cell differentiation (GO:0045623) | 1.97189621 |
| 157 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 1.97189621 |
| 158 | centrosome duplication (GO:0051298) | 1.97018580 |
| 159 | positive regulation of histone deacetylation (GO:0031065) | 1.96624549 |
| 160 | positive regulation of glial cell differentiation (GO:0045687) | 1.96479468 |
| 161 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 1.96434168 |
| 162 | histone lysine demethylation (GO:0070076) | 1.93620933 |
| 163 | plasma membrane repair (GO:0001778) | 1.93336534 |
| 164 | interleukin-6-mediated signaling pathway (GO:0070102) | 1.92486893 |
| 165 | positive regulation of Rap GTPase activity (GO:0032854) | 1.92436049 |
| 166 | positive thymic T cell selection (GO:0045059) | 1.92226690 |
| 167 | positive regulation of gliogenesis (GO:0014015) | 1.91989458 |
| 168 | glomerular basement membrane development (GO:0032836) | 1.91554775 |
| 169 | histone H3-K9 modification (GO:0061647) | 1.91533361 |
| 170 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 1.91409225 |
| 171 | Leydig cell differentiation (GO:0033327) | 1.90685363 |
| 172 | face morphogenesis (GO:0060325) | 1.90670320 |
| 173 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 1.87756598 |
| 174 | negative thymic T cell selection (GO:0045060) | 1.87470542 |
| 175 | regulation of p38MAPK cascade (GO:1900744) | 1.87469093 |
| 176 | cellular response to nerve growth factor stimulus (GO:1990090) | 1.87328750 |
| 177 | response to nerve growth factor (GO:1990089) | 1.87328750 |
| 178 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 1.86840449 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.92267586 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 3.06406261 |
| 3 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.55367705 |
| 4 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.43971792 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 2.31545595 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.19886697 |
| 7 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.19320877 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.14055697 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.10117936 |
| 10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.95962573 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.90043480 |
| 12 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.86849404 |
| 13 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.83057928 |
| 14 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.80948872 |
| 15 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.77078923 |
| 16 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.75658593 |
| 17 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.74266944 |
| 18 | TP53_16413492_ChIP-PET_HCT116_Human | 1.70076396 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.69702292 |
| 20 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.68216968 |
| 21 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.67363550 |
| 22 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.66792335 |
| 23 | GATA2_19941826_ChIP-Seq_K562_Human | 1.63351401 |
| 24 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.62654247 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.62547243 |
| 26 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.57951457 |
| 27 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.57011343 |
| 28 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.51422271 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.50464012 |
| 30 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.50363383 |
| 31 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.46155420 |
| 32 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.43938568 |
| 33 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.41300699 |
| 34 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.41049825 |
| 35 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.40885484 |
| 36 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40547213 |
| 37 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.36851728 |
| 38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36019783 |
| 39 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.33177379 |
| 40 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32376741 |
| 41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.31875586 |
| 42 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.31642338 |
| 43 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.31318171 |
| 44 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.31098696 |
| 45 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.28673753 |
| 46 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28287388 |
| 47 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27646118 |
| 48 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.27504419 |
| 49 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.26389648 |
| 50 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.24928064 |
| 51 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.24928064 |
| 52 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.24920689 |
| 53 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.24877659 |
| 54 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.22731985 |
| 55 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.22048246 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.21014205 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20972133 |
| 58 | STAT3_23295773_ChIP-Seq_U87_Human | 1.20086883 |
| 59 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.19952483 |
| 60 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.19671434 |
| 61 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19598741 |
| 62 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.18468516 |
| 63 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.18423915 |
| 64 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.17811124 |
| 65 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17232730 |
| 66 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16378814 |
| 67 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.14190826 |
| 68 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.14067998 |
| 69 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13649578 |
| 70 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.13450870 |
| 71 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.11673275 |
| 72 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.11431824 |
| 73 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.11048040 |
| 74 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.10984835 |
| 75 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.10179048 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09876805 |
| 77 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09569881 |
| 78 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08455710 |
| 79 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.08415465 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08045513 |
| 81 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.07803709 |
| 82 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.07596516 |
| 83 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.06857001 |
| 84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06814545 |
| 85 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06392521 |
| 86 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06392392 |
| 87 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.06110771 |
| 88 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.05967448 |
| 89 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.05648375 |
| 90 | TBL1_22424771_ChIP-Seq_293T_Human | 1.05429390 |
| 91 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05353746 |
| 92 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.05003621 |
| 93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04714676 |
| 94 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.04638633 |
| 95 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04276360 |
| 96 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.03394127 |
| 97 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.03348550 |
| 98 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.03230821 |
| 99 | * MAF_26560356_Chip-Seq_TH1_Human | 1.03170309 |
| 100 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03101043 |
| 101 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02839867 |
| 102 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.02407864 |
| 103 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.02372829 |
| 104 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.01706964 |
| 105 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.00619546 |
| 106 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.00424261 |
| 107 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99873188 |
| 108 | KDM2B_26808549_Chip-Seq_K562_Human | 0.99349867 |
| 109 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99242383 |
| 110 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98710946 |
| 111 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.97698792 |
| 112 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96466811 |
| 113 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95638227 |
| 114 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95521241 |
| 115 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95213294 |
| 116 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.94876566 |
| 117 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94839744 |
| 118 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94615949 |
| 119 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.93823336 |
| 120 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93496509 |
| 121 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93348284 |
| 122 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.92869812 |
| 123 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92794805 |
| 124 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.91882246 |
| 125 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91842614 |
| 126 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.91662063 |
| 127 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.91587203 |
| 128 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.91315758 |
| 129 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.89977349 |
| 130 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.88943177 |
| 131 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88021021 |
| 132 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88001376 |
| 133 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.87553350 |
| 134 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.87404220 |
| 135 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.85251468 |
| 136 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85155923 |
| 137 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85155923 |
| 138 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85121185 |
| 139 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.84650575 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003656_abnormal_erythrocyte_physiolo | 3.48536186 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.32805805 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.31273160 |
| 4 | MP0005623_abnormal_meninges_morphology | 3.08689715 |
| 5 | MP0000920_abnormal_myelination | 3.00995543 |
| 6 | MP0005451_abnormal_body_composition | 2.51657281 |
| 7 | MP0000569_abnormal_digit_pigmentation | 2.32541438 |
| 8 | MP0000383_abnormal_hair_follicle | 2.31606391 |
| 9 | MP0010678_abnormal_skin_adnexa | 2.25250396 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.21025151 |
| 11 | MP0000733_abnormal_muscle_development | 2.17166047 |
| 12 | MP0004084_abnormal_cardiac_muscle | 2.14887656 |
| 13 | MP0008260_abnormal_autophagy | 2.11549374 |
| 14 | MP0002009_preneoplasia | 2.08086472 |
| 15 | MP0003045_fibrosis | 2.02935559 |
| 16 | MP0004510_myositis | 2.01745484 |
| 17 | MP0003091_abnormal_cell_migration | 1.96569757 |
| 18 | MP0004130_abnormal_muscle_cell | 1.94018113 |
| 19 | MP0004185_abnormal_adipocyte_glucose | 1.91845106 |
| 20 | MP0003763_abnormal_thymus_physiology | 1.91104943 |
| 21 | MP0004808_abnormal_hematopoietic_stem | 1.87961628 |
| 22 | MP0005275_abnormal_skin_tensile | 1.84156363 |
| 23 | MP0002166_altered_tumor_susceptibility | 1.78781218 |
| 24 | MP0004381_abnormal_hair_follicle | 1.78168971 |
| 25 | MP0002396_abnormal_hematopoietic_system | 1.76159837 |
| 26 | MP0004036_abnormal_muscle_relaxation | 1.73940433 |
| 27 | MP0003690_abnormal_glial_cell | 1.73831964 |
| 28 | MP0001299_abnormal_eye_distance/ | 1.73335098 |
| 29 | MP0005076_abnormal_cell_differentiation | 1.71903889 |
| 30 | MP0004233_abnormal_muscle_weight | 1.65751142 |
| 31 | MP0003828_pulmonary_edema | 1.62806656 |
| 32 | MP0005409_darkened_coat_color | 1.59576587 |
| 33 | MP0004272_abnormal_basement_membrane | 1.56384862 |
| 34 | * MP0010630_abnormal_cardiac_muscle | 1.55675166 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.54514620 |
| 36 | MP0004087_abnormal_muscle_fiber | 1.52102794 |
| 37 | MP0004885_abnormal_endolymph | 1.46641194 |
| 38 | MP0008057_abnormal_DNA_replication | 1.45428606 |
| 39 | MP0002877_abnormal_melanocyte_morpholog | 1.43497947 |
| 40 | MP0001851_eye_inflammation | 1.43014577 |
| 41 | MP0008438_abnormal_cutaneous_collagen | 1.42333534 |
| 42 | MP0010234_abnormal_vibrissa_follicle | 1.42139934 |
| 43 | MP0000747_muscle_weakness | 1.41432908 |
| 44 | MP0003566_abnormal_cell_adhesion | 1.41179218 |
| 45 | MP0004145_abnormal_muscle_electrophysio | 1.33847258 |
| 46 | MP0000751_myopathy | 1.31811359 |
| 47 | MP0005621_abnormal_cell_physiology | 1.30080935 |
| 48 | MP0003303_peritoneal_inflammation | 1.26828613 |
| 49 | MP0008877_abnormal_DNA_methylation | 1.26259526 |
| 50 | MP0001348_abnormal_lacrimal_gland | 1.26181104 |
| 51 | MP0006138_congestive_heart_failure | 1.25086698 |
| 52 | MP0001346_abnormal_lacrimal_gland | 1.23460592 |
| 53 | MP0000767_abnormal_smooth_muscle | 1.23067206 |
| 54 | MP0003937_abnormal_limbs/digits/tail_de | 1.22831914 |
| 55 | MP0003634_abnormal_glial_cell | 1.20659583 |
| 56 | MP0003787_abnormal_imprinting | 1.20096927 |
| 57 | MP0002106_abnormal_muscle_physiology | 1.18604572 |
| 58 | MP0005171_absent_coat_pigmentation | 1.17075731 |
| 59 | MP0002006_tumorigenesis | 1.16833839 |
| 60 | MP0008775_abnormal_heart_ventricle | 1.16548336 |
| 61 | * MP0002925_abnormal_cardiovascular_devel | 1.15239863 |
| 62 | MP0004742_abnormal_vestibular_system | 1.13753842 |
| 63 | MP0003136_yellow_coat_color | 1.13002072 |
| 64 | MP0001790_abnormal_immune_system | 1.12095821 |
| 65 | MP0005387_immune_system_phenotype | 1.12095821 |
| 66 | MP0001958_emphysema | 1.11654202 |
| 67 | MP0001879_abnormal_lymphatic_vessel | 1.11364969 |
| 68 | MP0005375_adipose_tissue_phenotype | 1.10746784 |
| 69 | MP0005666_abnormal_adipose_tissue | 1.09938351 |
| 70 | MP0002796_impaired_skin_barrier | 1.07037279 |
| 71 | MP0003329_amyloid_beta_deposits | 1.06509585 |
| 72 | MP0005330_cardiomyopathy | 1.04520056 |
| 73 | * MP0003984_embryonic_growth_retardation | 1.04494803 |
| 74 | MP0005310_abnormal_salivary_gland | 1.04096379 |
| 75 | MP0005369_muscle_phenotype | 1.03335448 |
| 76 | MP0000428_abnormal_craniofacial_morphol | 1.03270533 |
| 77 | MP0003632_abnormal_nervous_system | 1.02614317 |
| 78 | MP0009278_abnormal_bone_marrow | 1.01939253 |
| 79 | MP0000749_muscle_degeneration | 1.01095493 |
| 80 | MP0001545_abnormal_hematopoietic_system | 1.00333501 |
| 81 | MP0005397_hematopoietic_system_phenotyp | 1.00333501 |
| 82 | MP0008569_lethality_at_weaning | 1.00318568 |
| 83 | MP0009672_abnormal_birth_weight | 0.99601091 |
| 84 | * MP0002088_abnormal_embryonic_growth/wei | 0.99491680 |
| 85 | MP0001661_extended_life_span | 0.99401233 |
| 86 | MP0000003_abnormal_adipose_tissue | 0.98970243 |
| 87 | MP0000703_abnormal_thymus_morphology | 0.98849621 |
| 88 | * MP0001784_abnormal_fluid_regulation | 0.98366401 |
| 89 | MP0003115_abnormal_respiratory_system | 0.98223035 |
| 90 | MP0001730_embryonic_growth_arrest | 0.95883270 |
| 91 | MP0002972_abnormal_cardiac_muscle | 0.95131998 |
| 92 | MP0000579_abnormal_nail_morphology | 0.94326157 |
| 93 | MP0004947_skin_inflammation | 0.94211588 |
| 94 | MP0000759_abnormal_skeletal_muscle | 0.93367555 |
| 95 | * MP0001915_intracranial_hemorrhage | 0.92936177 |
| 96 | MP0004264_abnormal_extraembryonic_tissu | 0.92712728 |
| 97 | MP0009115_abnormal_fat_cell | 0.92320635 |
| 98 | MP0004859_abnormal_synaptic_plasticity | 0.90700583 |
| 99 | MP0003279_aneurysm | 0.90302535 |
| 100 | MP0003890_abnormal_embryonic-extraembry | 0.89223678 |
| 101 | MP0003453_abnormal_keratinocyte_physiol | 0.89173713 |
| 102 | MP0002933_joint_inflammation | 0.89047784 |
| 103 | * MP0002086_abnormal_extraembryonic_tissu | 0.89006251 |
| 104 | MP0002108_abnormal_muscle_morphology | 0.88986098 |
| 105 | MP0004147_increased_porphyrin_level | 0.88933187 |
| 106 | MP0000432_abnormal_head_morphology | 0.88795798 |
| 107 | MP0003935_abnormal_craniofacial_develop | 0.87289966 |
| 108 | MP0002971_abnormal_brown_adipose | 0.87101142 |
| 109 | MP0005620_abnormal_muscle_contractility | 0.86924871 |
| 110 | MP0003221_abnormal_cardiomyocyte_apopto | 0.86285443 |
| 111 | MP0002060_abnormal_skin_morphology | 0.85238405 |
| 112 | MP0009384_cardiac_valve_regurgitation | 0.84037920 |
| 113 | MP0002269_muscular_atrophy | 0.82871854 |
| 114 | MP0004484_altered_response_of | 0.82541157 |
| 115 | * MP0000266_abnormal_heart_morphology | 0.82227041 |
| 116 | MP0000015_abnormal_ear_pigmentation | 0.82106670 |
| 117 | MP0002133_abnormal_respiratory_system | 0.80799972 |
| 118 | MP0005388_respiratory_system_phenotype | 0.80799972 |
| 119 | MP0005083_abnormal_biliary_tract | 0.80590114 |
| 120 | * MP0005380_embryogenesis_phenotype | 0.79928318 |
| 121 | * MP0001672_abnormal_embryogenesis/_devel | 0.79928318 |
| 122 | MP0010352_gastrointestinal_tract_polyps | 0.79502064 |
| 123 | MP0004134_abnormal_chest_morphology | 0.79024326 |
| 124 | MP0001544_abnormal_cardiovascular_syste | 0.77647178 |
| 125 | MP0005385_cardiovascular_system_phenoty | 0.77647178 |
| 126 | MP0002168_other_aberrant_phenotype | 0.77625847 |
| 127 | MP0000350_abnormal_cell_proliferation | 0.76539792 |
| 128 | MP0000750_abnormal_muscle_regeneration | 0.76003747 |
| 129 | MP0004215_abnormal_myocardial_fiber | 0.75027052 |
| 130 | * MP0001614_abnormal_blood_vessel | 0.73803604 |
| 131 | * MP0002128_abnormal_blood_circulation | 0.73722316 |
| 132 | MP0001485_abnormal_pinna_reflex | 0.73572340 |
| 133 | MP0005384_cellular_phenotype | 0.73511044 |
| 134 | MP0008961_abnormal_basal_metabolism | 0.73068190 |
| 135 | MP0000778_abnormal_nervous_system | 0.71112688 |
| 136 | MP0003191_abnormal_cellular_cholesterol | 0.70836154 |
| 137 | MP0005410_abnormal_fertilization | 0.70432076 |
| 138 | MP0010307_abnormal_tumor_latency | 0.69008874 |
| 139 | MP0009703_decreased_birth_body | 0.68506501 |
| 140 | MP0003385_abnormal_body_wall | 0.66693963 |
| 141 | MP0010368_abnormal_lymphatic_system | 0.66430993 |
| 142 | MP0009780_abnormal_chondrocyte_physiolo | 0.64902444 |
| 143 | MP0003567_abnormal_fetal_cardiomyocyte | 0.64360918 |
| 144 | MP0002084_abnormal_developmental_patter | 0.64193863 |
| 145 | MP0000647_abnormal_sebaceous_gland | 0.63416608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyporeflexia of lower limbs (HP:0002600) | 4.11176570 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.65343984 |
| 3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.65343984 |
| 4 | Obstructive sleep apnea (HP:0002870) | 3.34727363 |
| 5 | Muscle fiber splitting (HP:0003555) | 3.22337352 |
| 6 | Dysmetric saccades (HP:0000641) | 3.21272835 |
| 7 | Abnormality of the fingertips (HP:0001211) | 3.13843067 |
| 8 | Difficulty running (HP:0009046) | 3.07222202 |
| 9 | Macroorchidism (HP:0000053) | 3.03761038 |
| 10 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.89915461 |
| 11 | Onion bulb formation (HP:0003383) | 2.82004639 |
| 12 | Hypoplastic ischia (HP:0003175) | 2.73064566 |
| 13 | Poikilocytosis (HP:0004447) | 2.58954150 |
| 14 | Neurofibrillary tangles (HP:0002185) | 2.54540042 |
| 15 | Broad face (HP:0000283) | 2.51404232 |
| 16 | Sensory axonal neuropathy (HP:0003390) | 2.46331580 |
| 17 | Abnormality of the corticospinal tract (HP:0002492) | 2.43915365 |
| 18 | Overgrowth (HP:0001548) | 2.39808133 |
| 19 | Scapular winging (HP:0003691) | 2.38818213 |
| 20 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.34592899 |
| 21 | Hypoplasia of the iris (HP:0007676) | 2.33839973 |
| 22 | Abnormality of the ischium (HP:0003174) | 2.32823788 |
| 23 | Termporal pattern (HP:0011008) | 2.32112151 |
| 24 | Insidious onset (HP:0003587) | 2.32112151 |
| 25 | Peripheral hypomyelination (HP:0007182) | 2.31747703 |
| 26 | Dislocated radial head (HP:0003083) | 2.29282430 |
| 27 | Narrow palate (HP:0000189) | 2.25734341 |
| 28 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.23247587 |
| 29 | Subaortic stenosis (HP:0001682) | 2.23247587 |
| 30 | Shallow orbits (HP:0000586) | 2.21786612 |
| 31 | Cerebral inclusion bodies (HP:0100314) | 2.20136128 |
| 32 | Calf muscle hypertrophy (HP:0008981) | 2.19524568 |
| 33 | Abnormal auditory evoked potentials (HP:0006958) | 2.18861093 |
| 34 | Subacute progressive viral hepatitis (HP:0006572) | 2.17732323 |
| 35 | Volvulus (HP:0002580) | 2.10707234 |
| 36 | Truncal obesity (HP:0001956) | 2.10203957 |
| 37 | Neonatal hypoglycemia (HP:0001998) | 2.08778438 |
| 38 | Abnormality of the nasal septum (HP:0000419) | 2.07559890 |
| 39 | Germ cell neoplasia (HP:0100728) | 2.07457119 |
| 40 | Right ventricular cardiomyopathy (HP:0011663) | 2.06716094 |
| 41 | Absent frontal sinuses (HP:0002688) | 2.06245617 |
| 42 | Abnormality of the radial head (HP:0003995) | 2.06136064 |
| 43 | Cerebral aneurysm (HP:0004944) | 2.06108965 |
| 44 | Lip pit (HP:0100267) | 2.04546810 |
| 45 | Disproportionate tall stature (HP:0001519) | 2.02855632 |
| 46 | Long eyelashes (HP:0000527) | 2.02030316 |
| 47 | Increased connective tissue (HP:0009025) | 2.01559294 |
| 48 | Premature skin wrinkling (HP:0100678) | 1.99697439 |
| 49 | Depressed nasal tip (HP:0000437) | 1.99286300 |
| 50 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.99246118 |
| 51 | Hyperacusis (HP:0010780) | 1.99242547 |
| 52 | Persistence of primary teeth (HP:0006335) | 1.98798355 |
| 53 | Arterial tortuosity (HP:0005116) | 1.96511228 |
| 54 | Distal lower limb amyotrophy (HP:0008944) | 1.95496618 |
| 55 | Mitral valve prolapse (HP:0001634) | 1.95205775 |
| 56 | Sudden death (HP:0001699) | 1.93682341 |
| 57 | Trigonocephaly (HP:0000243) | 1.93507269 |
| 58 | Foot dorsiflexor weakness (HP:0009027) | 1.93074163 |
| 59 | Slow saccadic eye movements (HP:0000514) | 1.92307066 |
| 60 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.90807567 |
| 61 | Anteriorly placed anus (HP:0001545) | 1.90326968 |
| 62 | Hematochezia (HP:0002573) | 1.89947098 |
| 63 | Deep philtrum (HP:0002002) | 1.88473129 |
| 64 | Widely spaced teeth (HP:0000687) | 1.87542525 |
| 65 | Chin dimple (HP:0010751) | 1.87269015 |
| 66 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.87228288 |
| 67 | Ankyloglossia (HP:0010296) | 1.87055507 |
| 68 | Lower limb amyotrophy (HP:0007210) | 1.86760071 |
| 69 | Pulmonary artery stenosis (HP:0004415) | 1.86244740 |
| 70 | Spondylolisthesis (HP:0003302) | 1.85843794 |
| 71 | Atrial fibrillation (HP:0005110) | 1.85807261 |
| 72 | Abnormality of the foot musculature (HP:0001436) | 1.85474632 |
| 73 | Gowers sign (HP:0003391) | 1.83379385 |
| 74 | Abnormality of the salivary glands (HP:0010286) | 1.82983414 |
| 75 | Broad metatarsal (HP:0001783) | 1.82934631 |
| 76 | Bell-shaped thorax (HP:0001591) | 1.82893026 |
| 77 | Supernumerary ribs (HP:0005815) | 1.82688198 |
| 78 | Abnormality of the calf musculature (HP:0001430) | 1.82266181 |
| 79 | Mask-like facies (HP:0000298) | 1.80486622 |
| 80 | Advanced eruption of teeth (HP:0006288) | 1.79272464 |
| 81 | Abnormality of the columella (HP:0009929) | 1.79246916 |
| 82 | Resting tremor (HP:0002322) | 1.78443816 |
| 83 | Postural instability (HP:0002172) | 1.77540299 |
| 84 | Relative macrocephaly (HP:0004482) | 1.77190686 |
| 85 | Aneurysm (HP:0002617) | 1.76643649 |
| 86 | Syringomyelia (HP:0003396) | 1.76569508 |
| 87 | Spinal cord lesions (HP:0100561) | 1.76569508 |
| 88 | Ectopic kidney (HP:0000086) | 1.76455108 |
| 89 | Limited hip movement (HP:0008800) | 1.75735593 |
| 90 | Scanning speech (HP:0002168) | 1.75669560 |
| 91 | Increased variability in muscle fiber diameter (HP:0003557) | 1.75351162 |
| 92 | Limited elbow extension (HP:0001377) | 1.75082127 |
| 93 | Decreased motor nerve conduction velocity (HP:0003431) | 1.73169191 |
| 94 | Vascular tortuosity (HP:0004948) | 1.73051522 |
| 95 | Obsessive-compulsive behavior (HP:0000722) | 1.72907599 |
| 96 | Aplasia cutis congenita (HP:0001057) | 1.71410405 |
| 97 | Laryngomalacia (HP:0001601) | 1.71199067 |
| 98 | Insomnia (HP:0100785) | 1.70197219 |
| 99 | Hip contracture (HP:0003273) | 1.69946904 |
| 100 | Low anterior hairline (HP:0000294) | 1.68496021 |
| 101 | Vertebral arch anomaly (HP:0008438) | 1.68112701 |
| 102 | Cubitus valgus (HP:0002967) | 1.67060669 |
| 103 | Prominent nose (HP:0000448) | 1.67002495 |
| 104 | Abnormality of chromosome segregation (HP:0002916) | 1.66335850 |
| 105 | Round ear (HP:0100830) | 1.65568819 |
| 106 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.64724718 |
| 107 | EMG: myopathic abnormalities (HP:0003458) | 1.64303473 |
| 108 | Abnormality of the frontal sinuses (HP:0002687) | 1.64120265 |
| 109 | Acute myeloid leukemia (HP:0004808) | 1.63799005 |
| 110 | Heterotopia (HP:0002282) | 1.63501048 |
| 111 | Genetic anticipation (HP:0003743) | 1.63359660 |
| 112 | Bowel incontinence (HP:0002607) | 1.63064543 |
| 113 | Flat acetabular roof (HP:0003180) | 1.62824673 |
| 114 | Bundle branch block (HP:0011710) | 1.62142063 |
| 115 | Metaphyseal cupping (HP:0003021) | 1.62121723 |
| 116 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.61930486 |
| 117 | Primary atrial arrhythmia (HP:0001692) | 1.61927659 |
| 118 | Exercise-induced myalgia (HP:0003738) | 1.61614671 |
| 119 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.61564501 |
| 120 | Premature rupture of membranes (HP:0001788) | 1.61201879 |
| 121 | Polycythemia (HP:0001901) | 1.60073433 |
| 122 | Thick nail (HP:0001805) | 1.60066633 |
| 123 | Hypochromic microcytic anemia (HP:0004840) | 1.59871641 |
| 124 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.59324165 |
| 125 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.59277152 |
| 126 | Asymmetry of the thorax (HP:0001555) | 1.59048818 |
| 127 | Spontaneous hematomas (HP:0007420) | 1.58900846 |
| 128 | Precocious puberty (HP:0000826) | 1.58263705 |
| 129 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.58208502 |
| 130 | Aqueductal stenosis (HP:0002410) | 1.57448939 |
| 131 | Infantile muscular hypotonia (HP:0008947) | 1.57268180 |
| 132 | Broad palm (HP:0001169) | 1.57152711 |
| 133 | EMG: neuropathic changes (HP:0003445) | 1.56811994 |
| 134 | Supranuclear gaze palsy (HP:0000605) | 1.56225715 |
| 135 | Sandal gap (HP:0001852) | 1.56202940 |
| 136 | Dysmetria (HP:0001310) | 1.55261522 |
| 137 | Midline defect of the nose (HP:0004122) | 1.55050969 |
| 138 | Aortic aneurysm (HP:0004942) | 1.54927220 |
| 139 | Exercise-induced muscle cramps (HP:0003710) | 1.53597924 |
| 140 | Abnormality of nail color (HP:0100643) | 1.52830065 |
| 141 | Abnormality of the parietal bone (HP:0002696) | 1.52804970 |
| 142 | Reticulocytosis (HP:0001923) | 1.50713493 |
| 143 | Menstrual irregularities (HP:0000858) | 1.50662236 |
| 144 | Urethral obstruction (HP:0000796) | 1.50552059 |
| 145 | Thick eyebrow (HP:0000574) | 1.50414340 |
| 146 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.50220317 |
| 147 | Papillary thyroid carcinoma (HP:0002895) | 1.49905091 |
| 148 | Parakeratosis (HP:0001036) | 1.49665290 |
| 149 | Spastic gait (HP:0002064) | 1.49581603 |
| 150 | Abnormal vertebral ossification (HP:0100569) | 1.49029255 |
| 151 | Abnormality of incisor morphology (HP:0011063) | 1.48691010 |
| 152 | Ulnar bowing (HP:0003031) | 1.48356656 |
| 153 | Uterine leiomyosarcoma (HP:0002891) | 1.48355347 |
| 154 | Leiomyosarcoma (HP:0100243) | 1.48355347 |
| 155 | Hammertoe (HP:0001765) | 1.48269868 |
| 156 | Abnormality of oral frenula (HP:0000190) | 1.48189936 |
| 157 | Coronal craniosynostosis (HP:0004440) | 1.47816928 |
| 158 | Bladder carcinoma (HP:0002862) | 1.47767625 |
| 159 | Bladder neoplasm (HP:0009725) | 1.47767625 |
| 160 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.47725430 |
| 161 | Aortic dissection (HP:0002647) | 1.47111732 |
| 162 | Sparse lateral eyebrow (HP:0005338) | 1.47027338 |
| 163 | Short 4th metacarpal (HP:0010044) | 1.46820159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.35798888 |
| 2 | CDK12 | 3.97063766 |
| 3 | EPHB1 | 3.64423630 |
| 4 | TRIB3 | 2.93337966 |
| 5 | CAMK1G | 2.69902874 |
| 6 | DMPK | 2.58627681 |
| 7 | WNK4 | 2.46688986 |
| 8 | BRD4 | 2.42512816 |
| 9 | CAMK1D | 2.34694851 |
| 10 | LATS1 | 2.34369828 |
| 11 | OXSR1 | 2.22590341 |
| 12 | EEF2K | 2.21297741 |
| 13 | TTN | 2.10860740 |
| 14 | MAP3K10 | 2.10297736 |
| 15 | SGK2 | 2.00648462 |
| 16 | ICK | 1.97091689 |
| 17 | FGFR2 | 1.81970221 |
| 18 | FGFR4 | 1.74265928 |
| 19 | PKN1 | 1.69409817 |
| 20 | SMG1 | 1.67051832 |
| 21 | PNCK | 1.60786640 |
| 22 | STK3 | 1.60280509 |
| 23 | RIPK4 | 1.56475884 |
| 24 | TRPM7 | 1.46189835 |
| 25 | STK10 | 1.44085619 |
| 26 | CSNK1A1L | 1.41596533 |
| 27 | KSR2 | 1.38442125 |
| 28 | MET | 1.33852291 |
| 29 | MAP3K2 | 1.30512888 |
| 30 | AKT3 | 1.29136441 |
| 31 | PDGFRB | 1.28713612 |
| 32 | MAP3K14 | 1.24767473 |
| 33 | * WNK1 | 1.22799202 |
| 34 | BCR | 1.21774948 |
| 35 | MAP2K3 | 1.19041231 |
| 36 | TAOK1 | 1.16287308 |
| 37 | CLK1 | 1.13403109 |
| 38 | ROCK2 | 1.09487128 |
| 39 | ITK | 1.06085772 |
| 40 | JAK1 | 1.04911662 |
| 41 | NUAK1 | 1.04874243 |
| 42 | NEK9 | 1.04729473 |
| 43 | FGR | 1.03872118 |
| 44 | NLK | 1.02214114 |
| 45 | MAP3K13 | 0.99651252 |
| 46 | OBSCN | 0.99449035 |
| 47 | MELK | 0.98563339 |
| 48 | PRKD1 | 0.95850393 |
| 49 | * MTOR | 0.95597119 |
| 50 | TYRO3 | 0.94190873 |
| 51 | EIF2AK1 | 0.93522781 |
| 52 | SIK1 | 0.92976154 |
| 53 | CAMK4 | 0.92486606 |
| 54 | PRKCQ | 0.89398613 |
| 55 | PAK3 | 0.89031063 |
| 56 | NEK6 | 0.88447639 |
| 57 | STK38 | 0.86786154 |
| 58 | STK4 | 0.86350697 |
| 59 | PRKAA2 | 0.85650692 |
| 60 | MARK2 | 0.81748768 |
| 61 | SIK2 | 0.81664626 |
| 62 | CDK9 | 0.81343935 |
| 63 | CSNK1D | 0.80421251 |
| 64 | YES1 | 0.79904522 |
| 65 | CAMKK1 | 0.79590823 |
| 66 | PRKD3 | 0.79477265 |
| 67 | KSR1 | 0.79465281 |
| 68 | EPHA3 | 0.79447233 |
| 69 | FGFR3 | 0.78464207 |
| 70 | MAPK12 | 0.77699794 |
| 71 | MAP3K1 | 0.77642211 |
| 72 | JAK3 | 0.77181488 |
| 73 | MAP3K7 | 0.77041247 |
| 74 | PKN2 | 0.76731848 |
| 75 | RIPK1 | 0.76659486 |
| 76 | PTK6 | 0.76630521 |
| 77 | TGFBR2 | 0.76306550 |
| 78 | CHUK | 0.76156417 |
| 79 | BMX | 0.74138065 |
| 80 | CSK | 0.72122424 |
| 81 | CSNK1G1 | 0.72109406 |
| 82 | INSRR | 0.71563469 |
| 83 | CDK4 | 0.71307690 |
| 84 | STK11 | 0.70227007 |
| 85 | PRKCH | 0.69910991 |
| 86 | HIPK2 | 0.69784237 |
| 87 | PAK2 | 0.69623755 |
| 88 | MAPK11 | 0.69569843 |
| 89 | CDK6 | 0.65084294 |
| 90 | HCK | 0.65034321 |
| 91 | PRPF4B | 0.64221439 |
| 92 | CAMK1 | 0.64080136 |
| 93 | SGK494 | 0.64066895 |
| 94 | SGK223 | 0.64066895 |
| 95 | NTRK3 | 0.63799426 |
| 96 | PIK3CA | 0.63071370 |
| 97 | MAPK10 | 0.62344105 |
| 98 | ERN1 | 0.62265849 |
| 99 | MAP3K6 | 0.62240653 |
| 100 | CDC42BPA | 0.61828817 |
| 101 | PRKD2 | 0.60748149 |
| 102 | LATS2 | 0.60343732 |
| 103 | PTK2B | 0.60163735 |
| 104 | PDK1 | 0.59698510 |
| 105 | MAP4K1 | 0.59659548 |
| 106 | PTK2 | 0.58808301 |
| 107 | MAP3K3 | 0.58258463 |
| 108 | CSNK1G3 | 0.57939548 |
| 109 | MAPKAPK5 | 0.57004564 |
| 110 | ZAP70 | 0.55472149 |
| 111 | RET | 0.54341478 |
| 112 | ALK | 0.54076764 |
| 113 | MAPK7 | 0.53990410 |
| 114 | JAK2 | 0.53948103 |
| 115 | PHKG1 | 0.53716662 |
| 116 | PHKG2 | 0.53716662 |
| 117 | GSK3A | 0.53572253 |
| 118 | CAMK2D | 0.53299850 |
| 119 | SGK3 | 0.53222538 |
| 120 | PDGFRA | 0.53048121 |
| 121 | IKBKB | 0.52598437 |
| 122 | BLK | 0.51678428 |
| 123 | RAF1 | 0.51602592 |
| 124 | STK24 | 0.51583007 |
| 125 | PAK6 | 0.51474007 |
| 126 | PRKAA1 | 0.51121904 |
| 127 | ABL1 | 0.50897156 |
| 128 | ROCK1 | 0.50840691 |
| 129 | CSNK1G2 | 0.49868970 |
| 130 | UHMK1 | 0.47954595 |
| 131 | LCK | 0.47366888 |
| 132 | DYRK1A | 0.47069218 |
| 133 | ERBB2 | 0.46707246 |
| 134 | MAPK1 | 0.44382511 |
| 135 | INSR | 0.43906365 |
| 136 | * SGK1 | 0.42958514 |
| 137 | NTRK1 | 0.42510664 |
| 138 | PIM1 | 0.42467237 |
| 139 | FYN | 0.42066546 |
| 140 | MAPK15 | 0.41377070 |
| 141 | CSF1R | 0.41281149 |
| 142 | RPS6KA2 | 0.41258811 |
| 143 | EGFR | 0.40465318 |
| 144 | PDPK1 | 0.40204993 |
| 145 | FGFR1 | 0.39825097 |
| 146 | NTRK2 | 0.39042188 |
| 147 | RPS6KC1 | 0.38152502 |
| 148 | RPS6KL1 | 0.38152502 |
| 149 | TAOK2 | 0.37811310 |
| 150 | GSK3B | 0.37663864 |
| 151 | RPS6KB1 | 0.36835601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.09993073 |
| 2 | Long-term potentiation_Homo sapiens_hsa04720 | 1.74192415 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.68994415 |
| 4 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.59882360 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.57979288 |
| 6 | Viral myocarditis_Homo sapiens_hsa05416 | 1.55922342 |
| 7 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.50423073 |
| 8 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.50228002 |
| 9 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.49201179 |
| 10 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.48169164 |
| 11 | Focal adhesion_Homo sapiens_hsa04510 | 1.40838561 |
| 12 | Thyroid cancer_Homo sapiens_hsa05216 | 1.40559716 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.39794494 |
| 14 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.38746525 |
| 15 | Adherens junction_Homo sapiens_hsa04520 | 1.37263553 |
| 16 | Axon guidance_Homo sapiens_hsa04360 | 1.35896620 |
| 17 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.35638765 |
| 18 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.35301499 |
| 19 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.34131903 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32066206 |
| 21 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.30533466 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.25696172 |
| 23 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.24045146 |
| 24 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.23931391 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.23146300 |
| 26 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.21686628 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21193717 |
| 28 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.20283757 |
| 29 | Colorectal cancer_Homo sapiens_hsa05210 | 1.18346648 |
| 30 | Tight junction_Homo sapiens_hsa04530 | 1.18065367 |
| 31 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.17800559 |
| 32 | Allograft rejection_Homo sapiens_hsa05330 | 1.17431888 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16959949 |
| 34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.16397539 |
| 35 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.15197709 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.14871621 |
| 37 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.14652426 |
| 38 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.13804204 |
| 39 | Lysine degradation_Homo sapiens_hsa00310 | 1.13381416 |
| 40 | Prostate cancer_Homo sapiens_hsa05215 | 1.13379520 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09356274 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06906182 |
| 43 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.06584273 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05369487 |
| 45 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.03301644 |
| 46 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.00602452 |
| 47 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.98967884 |
| 48 | Endocytosis_Homo sapiens_hsa04144 | 0.98361165 |
| 49 | Amoebiasis_Homo sapiens_hsa05146 | 0.98070028 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 0.97999323 |
| 51 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.97829011 |
| 52 | Circadian rhythm_Homo sapiens_hsa04710 | 0.97779499 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.97293300 |
| 54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.96712084 |
| 55 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.95771636 |
| 56 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.94610512 |
| 57 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.94422949 |
| 58 | Hepatitis B_Homo sapiens_hsa05161 | 0.94245139 |
| 59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.93770330 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93178749 |
| 61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.92759636 |
| 62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92056157 |
| 63 | Pathways in cancer_Homo sapiens_hsa05200 | 0.90384082 |
| 64 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.90027930 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.89893009 |
| 66 | Malaria_Homo sapiens_hsa05144 | 0.89095973 |
| 67 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.88858245 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.88828888 |
| 69 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.88245698 |
| 70 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.87502746 |
| 71 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.87404471 |
| 72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.87026958 |
| 73 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.86397686 |
| 74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.85551027 |
| 75 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.84610230 |
| 76 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.84567003 |
| 77 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83776856 |
| 78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.82894162 |
| 79 | Measles_Homo sapiens_hsa05162 | 0.82408720 |
| 80 | Leishmaniasis_Homo sapiens_hsa05140 | 0.82194371 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81994084 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.81596160 |
| 83 | Renin secretion_Homo sapiens_hsa04924 | 0.81227247 |
| 84 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.81012908 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80369029 |
| 86 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.79798857 |
| 87 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.79487212 |
| 88 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.79326637 |
| 89 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.78809526 |
| 90 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.78701610 |
| 91 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.78349727 |
| 92 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78307928 |
| 93 | Melanogenesis_Homo sapiens_hsa04916 | 0.77489295 |
| 94 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.77093091 |
| 95 | Salmonella infection_Homo sapiens_hsa05132 | 0.76894623 |
| 96 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74977514 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.74580232 |
| 98 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.74479546 |
| 99 | Bladder cancer_Homo sapiens_hsa05219 | 0.74443235 |
| 100 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.74211560 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73389250 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | 0.73338775 |
| 103 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.73297883 |
| 104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.72882466 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70509501 |
| 106 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.70417134 |
| 107 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.69577444 |
| 108 | Gap junction_Homo sapiens_hsa04540 | 0.69471515 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.68713713 |
| 110 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.67835600 |
| 111 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.67512884 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.66866128 |
| 113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66768912 |
| 114 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.66131178 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66101735 |
| 116 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65739531 |
| 117 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65506290 |
| 118 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.64744868 |
| 119 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.64533042 |
| 120 | Glioma_Homo sapiens_hsa05214 | 0.64465571 |
| 121 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63954532 |
| 122 | Melanoma_Homo sapiens_hsa05218 | 0.62869897 |
| 123 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.62676971 |
| 124 | Shigellosis_Homo sapiens_hsa05131 | 0.62384466 |
| 125 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61693783 |
| 126 | Long-term depression_Homo sapiens_hsa04730 | 0.61654523 |
| 127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61575836 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60788459 |
| 129 | Apoptosis_Homo sapiens_hsa04210 | 0.60648646 |
| 130 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60450761 |
| 131 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.60316907 |
| 132 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60312805 |
| 133 | Influenza A_Homo sapiens_hsa05164 | 0.59464928 |
| 134 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.55447461 |

